US Biotech Firm Medivation Seeks $14Bln Merger With Rival Pfizer

The proposed acquisition of Medivation is expected to immediately accelerate revenue growth and drive overall earnings growth potential for Pfizer, according to Pfizer Chairman and Chief Executive Officer Ian Read.

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

Medivation [+]    Pfizer [+]   

More #news: